The results suggested that the mechanism of LINC00263 development in breast cancer and ovarian cancer might be different (Supplementary Fig. 6a, b).37 The mechanism of LINC00263 in breast cancer was related to estrogen receptors and might be associated with BRCA gene mutations in ovarian cancer. The gene discussed is ESR1; the disease is ovarian cancer.